Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β
Open Access
- 21 October 2022
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 27, 415-430
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (5 U01 CA239258-02)
- St. Jude Children's Research Hospital (4-1BBL-expressing K562)
This publication has 67 references indexed in Scilit:
- Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrowFrontiers in Immunology, 2013
- A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCRBlood, 2012
- Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa)Blood, 2012
- Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour ActivityPLOS ONE, 2011
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progressionTrends in Immunology, 2010
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activityBlood, 2009
- Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β ReceptorJournal of Immunotherapy, 2008
- Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cellsBlood, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005